Plain-English translation of NCT07336446 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help treat metastatic prostate cancer (cancer that has spread beyond the prostate). Researchers want to learn how safe the medication is, what dose works best, and whether it works better alone or when combined with other cancer treatments. The study will enroll around 300 people and follow a step-by-step approach to find the safest and most effective way to use this treatment.
Many people with advanced prostate cancer develop resistance to current hormone-blocking treatments over time. This trial exists to see whether this new medication offers another option for patients whose cancer has progressed despite earlier treatments.
You likely qualify if…
You likely don't qualify if…
You would take the new medication by mouth, either alone or combined with another cancer drug, depending on which part of the study you're in. You'll have regular visits to the clinic for blood tests, scans, and check-ups to monitor how well the treatment is working and watch for any side effects. Treatment continues until your cancer stops responding, you experience unacceptable side effects, or you decide to stop—whichever comes first. The study is designed in phases, starting with careful safety checks before moving to larger groups of patients.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States